Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Voyager names senior VP, finance

This article was originally published in Scrip

Executive Summary

Voyager Therapeutics, a gene therapy company developing treatments for diseases of the central nervous system, has named Jeff Goater – former vice-president of business development – senior vice-president of finance and business development. In this new role, Mr Goater will be responsible for overseeing finance, business development, and investor and public relations activities across the company. Mr Goater has served as vice-president of business development since the launch of Voyager in 2014. Prior to Voyager, he spent nearly a decade on Wall Street, most recently as a managing director at Evercore Partners.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC028603

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel